Immune suppression and carcinogenesis in hamsters during topical application of 7,12-dimethylbenz(a)anthracene.
D000818:Animals; D000917:Antibody Formation; D000961:Antilymphocyte Serum; D001551:Benz(a)Anthracenes / Q000494:pharmacology*; D002273:Carcinogens; D002471:Cell Transformation, Neoplastic; D006224:Cricetinae; D006386:Hemagglutination Tests; D006462:Hemolytic Plaque Technique; D007111:Immunity, Cellular; D007165:Immunosuppression Therapy; D008198:Lymph Nodes / Q000601:surgery; D008221:Lymphoid Tissue / Q000276:immunology; D009369:Neoplasms / Q000276:immunology*; D010212:Papilloma / Q000276:immunology; D011817:Rabbits / Q000276:immunology; D012867:Skin / Q000276:immunology; D016038:Skin Transplantation; D013156:Splenectomy; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D001551:Benz(a)Anthracenes; D002273:Carcinogens